Indirect comparison between abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer: a systematic review

This study was designed to evaluate the efficacy, tolerability, and sequential administration of abiraterone acetate (AA) and enzalutamide (Enz) for metastatic castration-resistant prostate cancer (mCRPC). A literature search was performed with PubMed, Embase, and Web of Science databases to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Wu, Teng-Yun, Chen, Qi, Shi, Xiao-Lei, Xiao, Guang-An, Zhao, Lin, Xu, Chuan-Liang, Zhou, Tie, Sun, Ying-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312218/
https://www.ncbi.nlm.nih.gov/pubmed/27212123
http://dx.doi.org/10.4103/1008-682X.178483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312218/
https://www.ncbi.nlm.nih.gov/pubmed/27212123
http://dx.doi.org/10.4103/1008-682X.178483

Ejemplares similares